Skip to main content
Caplight Logo









XtalPi

XtalPi

Public
Cambridge, MassachusettsHealthcarehttps://www.xtalpi.com

XtalPi is now publicly traded

The data on this page reflects XtalPi's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jun 13, 2024

Last Round

Follow-on Offering

Feb 19, 2025

Total Funding Raised

$1.18B

Company Overview

XtalPi is a research platform company that utilizes artificial intelligence (AI), quantum physics, and robotics to accelerate research and development in the life sciences and new materials industries. The company's Intelligent Digital Drug Discovery and Development (ID4) platform provides predictive models to improve the efficiency and success rate of drug discovery. It offers services and products to pharmaceutical, biotechnology, and chemical companies worldwide, with operations in both China and the United States. Founded in 2015 by physicists from MIT, the company went public on the Hong Kong Stock Exchange in June 2024.

Sector

Healthcare

AI Layer

Application

Keywords

Intelligent Digital Drug Discovery and Development (ID4) platformAI-powered drug discovery platformIntegrated AI and robotics R&D platformQuantum physics-based drug discoveryDrug discovery co-development partnershipComputational drug discovery serviceDrug discovery SaaS platformAI platform for materials scienceAutomation-aided chemical synthesisAutomated laboratory workstationGenerative chemistry softwareCrystal structure prediction serviceMolecular property prediction software

XtalPi Comparables

Compare XtalPi with similar companies based on industry and business-model similarity.

XtalPi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insilico Medicine
88%
Schrödinger
83%
Recursion Pharmaceuticals
83%

XtalPi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingFeb 19, 2025
IPOJun 13, 2024
Series DAug 11, 2021
Series CSep 28, 2020
Series B ExtensionOct 24, 2018
Series B
Jan 23, 2018

Key People

Founding team and executive leadership

Yide Alan Jiang

Director Board Of Directors, Chief Strategy Officer

Executive Team

XtalPi Investors

Notable investors and investment history

XtalPi Filings

Explore SEC and related filing metadata, where available.

XtalPi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range370
Year Founded2015
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?